Riskpilot← Back to searchSign inGet full accessViaMedici AB
ABDissolvedOrg 5566715487General medical practice activities · NACE 8621Est. 20040 employees
Revenue 2023
SEK 17M
-3% vs 2022
EBITDA margin
7.0%
-51% vs 2022
Equity ratio
19.4%
Financial strength
Net profit 2023
SEK 42K
+2000% vs 2022
| Revenue | SEK 17M | -3% |
| EBITDA | SEK 1,2M | -51% |
| Net profit | SEK 42K | +2000% |
| Total assets | SEK 5,7M | +14% |
| Equity | SEK 1,1M | +21% |
| Employees | 0 | — |
Legal name
ViaMedici AB
Org number
5566715487
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 december 2004
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Firman tecknas ensam av Ceder, André Christian
Company purpose
Föremålet för bolagets verksamhet är konsultverksamhet inom hälso- och sjukvård med särskild inriktning på utbildning i akut omhändertagande. Försäljning av medicinskteknisk utrustning och därmed förenlig utrustning. Ambulansuthyrning samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 12 580 | 14 940 | 13 959 | 10 385 | 13 091 | 17 583 | 17 009 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | 953 | 1 311 | 1 401 | 2 366 | 2 392 | 1 699 | 1 881 | 2 451 | 1 192 |
| Depreciation & amort. | −462 | −766 | −818 | −1 083 | −806 | −811 | −703 | −449 | −448 |
| EBIT | 491 | 545 | 583 | 1 283 | 1 586 | 888 | 1 178 | 2 002 | 744 |
| Net financials | −4 | 15 | −32 | −61 | −44 | −37 | −1 537 | −380 | −54 |
| Profit before tax | 357 | 558 | 538 | 978 | 1 287 | 1 021 | −466 | 159 | 140 |
| Tax | −106 | −145 | −172 | −259 | −322 | −244 | −0 | −157 | −98 |
| Net profit | 251 | 413 | 366 | 719 | 965 | 777 | −466 | 2 | 42 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 630 | 6 489 | 6 729 | 8 057 | 7 370 | 6 337 | 5 919 | 5 037 | 5 729 |
| Equity | 754 | 927 | 843 | 1 262 | 1 607 | 1 384 | 918 | 921 | 1 114 |
| Long-term debt | 0 | 400 | 1 261 | 417 | 83 | 0 | 181 | 1 121 | 0 |
| Short-term debt | 2 980 | 4 264 | 3 714 | 5 223 | 4 270 | 3 713 | 3 710 | 2 046 | 4 615 |
| Total debt | 2 980 | 4 664 | 4 975 | 5 640 | 4 353 | 3 713 | 3 891 | 3 167 | 4 615 |
EBITDA margin
7.0%
This company
15.8%
Market median
-56% vs market
20152023
Equity ratio
19.4%
This company
38.2%
Market median
-49% vs market
20152023
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20152023
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20152023
Asset turnover
2.97×
This company
1.12×
Market median
+165% vs market
20152023
Debt / equity
4.14×
This company
0.62×
Market median
-568% vs market
20152023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AC External Signatory | External Signatory | 2024 | — | — |
HN Chief Auditor | Chief Auditor | 2024 | — | — |
BL Chief Auditor | Chief Auditor | 2022 | — | — |
AM | Audit | 2020 | — | — |
CC Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Chairman | 2024 | — | — | |
| Deputy Board Member | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Safe Life AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Safe Life AB
ViaMedici AB Board members of ViaMedici AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| André Christian Ceder | External Signatory | 0 companies |
| Hans Nicklas Renström | Chief Auditor | 0 companies |
| Beata Lihammar | Chief Auditor | 0 companies |
| Anette Madelein Samzelius | Audit | 0 companies |
| Charlotte Catrine Holmstrand | Chief Auditor | 0 companies |
| Björn Joakim Jadeland | Board of Directors | 0 companies |
| Paulus Gustaf Michael Wallentin | Board of Directors | 0 companies |
| Carina Birgitta Jadeland | Deputy Board Member | 0 companies |
| Jimmy Ulf Eriksson | Chairman | 0 companies |
| Alexander Furat Albedj | Deputy Board Member | 0 companies |